Effect of non-invasive ventilation after extubation in critically ill patients with obesity in France: a multicentre, unblinded, pragmatic randomised clinical trial

医学 氧气疗法 随机对照试验 机械通风 中止 麻醉 鼻插管 病危 外科 重症监护医学 套管
作者
Audrey DE JONG,Anne Laure Bignon,François Stéphan,Thomas Godet,Jean‐Michel Constantin,Karim Asehnoune,Aude Sylvestre,Juliette Sautillet,Raïko Blondonnet,Martine Ferrandière,Philippe Séguin,Sigismond Lasocki,Amélie Rollé,Pierre-Marie Fayolle,Laurent Müller,Emmanuel Pardo,Nicolas Terzi,Séverin Ramin,Boris Jung,Paër-Sélim Abback
出处
期刊:The Lancet Respiratory Medicine [Elsevier BV]
卷期号:11 (6): 530-539 被引量:75
标识
DOI:10.1016/s2213-2600(22)00529-x
摘要

Non-invasive ventilation (NIV) and oxygen therapy (high-flow nasal oxygen [HFNO] or standard oxygen) following extubation have never been compared in critically ill patients with obesity. We aimed to compare NIV (alternating with HFNO or standard oxygen) and oxygen therapy (HFNO or standard oxygen) following extubation of critically ill patients with obesity.In this multicentre, parallel group, pragmatic randomised controlled trial, conducted in 39 intensive care units in France, critically ill patients with obesity undergoing extubation were randomly assigned (1:1) to either the NIV group or the oxygen therapy group. Two randomisations were performed: first, randomisation to either NIV or oxygen therapy, and second, randomisation to either HFNO or standard oxygen (also 1:1), which was nested within the first randomisation. Blinding of the randomisation was not possible, but the statistician was masked to group assignment. The primary outcome was treatment failure within 3 days after extubation, a composite of reintubation for mechanical ventilation, switch to the other study treatment, or premature discontinuation of study treatment. The primary outcome was analysed by intention to treat. Effect of medical and surgical status was assessed. The reintubation within 3 days was analysed by intention to treat and after a post-hoc crossover analysis. This study is registered with ClinicalTrials.gov, number NCT04014920.From Oct 2, 2019, to July 17, 2021, of the 1650 screened patients, 981 were enrolled. Treatment failure occurred in 66 (13·5%) of 490 patients in the NIV group and in 130 (26·5%) of 491 patients in the oxygen-therapy group (relative risk 0·43; 95% CI 0·31-0·60, p<0·0001). Medical or surgical status did not modify the effect of NIV group on the treatment-failure rate. Reintubation within 3 days after extubation was similar in the non-invasive ventilation group and in the oxygen therapy group in the intention-to-treat analysis (48 (10%) of 490 patients and 59 (12%) of 491 patients, p=0·26) and lower in the NIV group than in the oxygen-therapy group in the post-hoc cross-over (51 (9%) of 560 patients and 56 (13%) of 421 patients, p=0·037) analysis. No severe adverse events were reported.Among critically ill adults with obesity undergoing extubation, the use of NIV was effective to reduce treatment-failure within 3 days. Our results are relevant to clinical practice, supporting the use of NIV after extubation of critically ill patients with obesity. However, most of the difference in the primary outcome was due to patients in the oxygen therapy group switching to NIV, and more evidence is needed to conclude that an NIV strategy leads to improved patient-centred outcomes.French Ministry of Health.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
celiaaa完成签到 ,获得积分10
3秒前
FashionBoy的应助被科研通管家采纳,获得10
4秒前
cdercder的应助被科研通管家采纳,获得10
4秒前
顾矜的应助被科研通管家采纳,获得10
4秒前
Clover04的应助被科研通管家采纳,获得10
4秒前
科目三的应助被科研通管家采纳,获得10
4秒前
秋风的应助被gfydsl采纳,获得20
4秒前
molihuakai的应助被科研通管家采纳,获得10
5秒前
sagitar的应助被科研通管家采纳,获得20
5秒前
5秒前
月食完成签到,获得积分10
5秒前
传奇3的应助被科研通管家采纳,获得10
5秒前
NexusExplorer的应助被科研通管家采纳,获得10
5秒前
5秒前
Jasper的应助被科研通管家采纳,获得10
5秒前
烟花的应助被科研通管家采纳,获得10
5秒前
自由文博的应助被Fancy采纳,获得10
7秒前
ZZzz完成签到 ,获得积分10
9秒前
gala完成签到,获得积分10
9秒前
KBRS完成签到,获得积分10
9秒前
勤奋乌龟完成签到 ,获得积分10
10秒前
zengQL完成签到 ,获得积分10
11秒前
郎芳完成签到 ,获得积分10
14秒前
明亮的酸奶完成签到,获得积分10
15秒前
lingfeng888888完成签到,获得积分10
16秒前
刘一严完成签到 ,获得积分10
17秒前
qw完成签到,获得积分10
18秒前
CPU完成签到 ,获得积分10
18秒前
lucygaga完成签到 ,获得积分10
18秒前
ty完成签到 ,获得积分10
18秒前
dasfsdf完成签到,获得积分0
19秒前
qq完成签到,获得积分20
20秒前
takashi完成签到,获得积分10
21秒前
碧蓝丹烟完成签到,获得积分10
21秒前
22秒前
Motemp2发布了新的文献求助10
22秒前
马嘚嘚完成签到 ,获得积分10
24秒前
Andy完成签到 ,获得积分0
24秒前
优雅向露完成签到 ,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190389
求助须知:如何正确求助?哪些是违规求助? 9577468
关于积分的说明 21852694
捐赠科研通 7789080
什么是DOI,文献DOI怎么找? 3436376
关于科研通互助平台的介绍 2560180
邀请新用户注册赠送积分活动 2483032